nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—ABCC3—chronic kidney failure	0.278	0.385	CbGaD
Methotrexate—MTHFR—chronic kidney failure	0.176	0.244	CbGaD
Methotrexate—ABCC2—chronic kidney failure	0.153	0.212	CbGaD
Methotrexate—ALB—chronic kidney failure	0.0588	0.0815	CbGaD
Methotrexate—ABCB1—chronic kidney failure	0.0561	0.0778	CbGaD
Methotrexate—FOLR1—nephron—chronic kidney failure	0.00727	0.0739	CbGeAlD
Methotrexate—SLCO3A1—nephron—chronic kidney failure	0.003	0.0305	CbGeAlD
Methotrexate—SLC22A8—nephron—chronic kidney failure	0.00187	0.019	CbGeAlD
Methotrexate—ATIC—blood plasma—chronic kidney failure	0.00172	0.0175	CbGeAlD
Methotrexate—MTHFR—artery—chronic kidney failure	0.0017	0.0173	CbGeAlD
Methotrexate—Leucovorin—ABCC3—chronic kidney failure	0.00168	0.297	CrCbGaD
Methotrexate—FOLR1—nephron tubule—chronic kidney failure	0.00157	0.016	CbGeAlD
Methotrexate—SLC22A8—urine—chronic kidney failure	0.0015	0.0153	CbGeAlD
Methotrexate—FOLR1—renal system—chronic kidney failure	0.00143	0.0145	CbGeAlD
Methotrexate—FOLR1—kidney—chronic kidney failure	0.00138	0.014	CbGeAlD
Methotrexate—FOLR1—cortex of kidney—chronic kidney failure	0.00134	0.0137	CbGeAlD
Methotrexate—MTHFR—blood plasma—chronic kidney failure	0.00128	0.013	CbGeAlD
Methotrexate—ABCC11—gonad—chronic kidney failure	0.00123	0.0125	CbGeAlD
Methotrexate—SLC19A1—gonad—chronic kidney failure	0.00112	0.0114	CbGeAlD
Methotrexate—FOLR1—blood—chronic kidney failure	0.00111	0.0113	CbGeAlD
Methotrexate—PGD—blood plasma—chronic kidney failure	0.00111	0.0113	CbGeAlD
Methotrexate—Folic Acid—ABCC3—chronic kidney failure	0.00109	0.191	CrCbGaD
Methotrexate—GGH—nephron tubule—chronic kidney failure	0.00104	0.0106	CbGeAlD
Methotrexate—SLC19A1—digestive system—chronic kidney failure	0.00103	0.0104	CbGeAlD
Methotrexate—SLCO1B1—blood plasma—chronic kidney failure	0.00101	0.0102	CbGeAlD
Methotrexate—SLC19A1—blood—chronic kidney failure	0.000977	0.00993	CbGeAlD
Methotrexate—ABCC3—blood plasma—chronic kidney failure	0.000956	0.00972	CbGeAlD
Methotrexate—GGH—renal system—chronic kidney failure	0.000948	0.00964	CbGeAlD
Methotrexate—GGH—urethra—chronic kidney failure	0.000931	0.00947	CbGeAlD
Methotrexate—Leucovorin—ABCC2—chronic kidney failure	0.000926	0.163	CrCbGaD
Methotrexate—SLCO4C1—nephron tubule—chronic kidney failure	0.000925	0.0094	CbGeAlD
Methotrexate—GGH—kidney—chronic kidney failure	0.000916	0.00932	CbGeAlD
Methotrexate—GGH—cortex of kidney—chronic kidney failure	0.000893	0.00907	CbGeAlD
Methotrexate—GGH—gonad—chronic kidney failure	0.00085	0.00864	CbGeAlD
Methotrexate—SLCO4C1—renal system—chronic kidney failure	0.000841	0.00855	CbGeAlD
Methotrexate—FPGS—urethra—chronic kidney failure	0.000819	0.00832	CbGeAlD
Methotrexate—SLCO4C1—kidney—chronic kidney failure	0.000813	0.00826	CbGeAlD
Methotrexate—ATIC—renal system—chronic kidney failure	0.000806	0.00819	CbGeAlD
Methotrexate—ATIC—cardiovascular system—chronic kidney failure	0.000796	0.0081	CbGeAlD
Methotrexate—SLCO4C1—cortex of kidney—chronic kidney failure	0.000792	0.00805	CbGeAlD
Methotrexate—SLC46A1—digestive system—chronic kidney failure	0.00079	0.00803	CbGeAlD
Methotrexate—ABCC4—blood plasma—chronic kidney failure	0.000789	0.00802	CbGeAlD
Methotrexate—FPGS—cortex of kidney—chronic kidney failure	0.000785	0.00798	CbGeAlD
Methotrexate—ATIC—kidney—chronic kidney failure	0.000779	0.00792	CbGeAlD
Methotrexate—GGH—digestive system—chronic kidney failure	0.000778	0.0079	CbGeAlD
Methotrexate—GGH—blood—chronic kidney failure	0.000741	0.00753	CbGeAlD
Methotrexate—ATIC—gonad—chronic kidney failure	0.000723	0.00735	CbGeAlD
Methotrexate—SLC22A11—nephron tubule—chronic kidney failure	0.000716	0.00728	CbGeAlD
Methotrexate—Tetrahydrofolic acid—MTHFR—chronic kidney failure	0.000689	0.121	CrCbGaD
Methotrexate—Folic Acid—MTHFR—chronic kidney failure	0.000689	0.121	CrCbGaD
Methotrexate—FPGS—digestive system—chronic kidney failure	0.000684	0.00695	CbGeAlD
Methotrexate—SLC22A6—nephron tubule—chronic kidney failure	0.000675	0.00686	CbGeAlD
Methotrexate—SLCO1C1—renal system—chronic kidney failure	0.00067	0.00681	CbGeAlD
Methotrexate—ATIC—digestive system—chronic kidney failure	0.000661	0.00672	CbGeAlD
Methotrexate—SLCO4C1—blood—chronic kidney failure	0.000657	0.00668	CbGeAlD
Methotrexate—FPGS—blood—chronic kidney failure	0.000651	0.00662	CbGeAlD
Methotrexate—SLC22A11—renal system—chronic kidney failure	0.000651	0.00662	CbGeAlD
Methotrexate—SLCO1C1—kidney—chronic kidney failure	0.000648	0.00658	CbGeAlD
Methotrexate—SLC22A7—renal system—chronic kidney failure	0.000635	0.00646	CbGeAlD
Methotrexate—ATIC—blood—chronic kidney failure	0.00063	0.0064	CbGeAlD
Methotrexate—SLC22A11—kidney—chronic kidney failure	0.000629	0.0064	CbGeAlD
Methotrexate—SLC22A7—kidney—chronic kidney failure	0.000614	0.00624	CbGeAlD
Methotrexate—SLC22A11—cortex of kidney—chronic kidney failure	0.000613	0.00623	CbGeAlD
Methotrexate—TYMS—nephron tubule—chronic kidney failure	0.000601	0.00611	CbGeAlD
Methotrexate—SLC22A7—cortex of kidney—chronic kidney failure	0.000598	0.00608	CbGeAlD
Methotrexate—Tetrahydrofolic acid—ABCC2—chronic kidney failure	0.000597	0.105	CrCbGaD
Methotrexate—DHFR—nephron tubule—chronic kidney failure	0.000595	0.00605	CbGeAlD
Methotrexate—MTHFR—cardiovascular system—chronic kidney failure	0.000592	0.00602	CbGeAlD
Methotrexate—SLCO3A1—renal system—chronic kidney failure	0.000589	0.00599	CbGeAlD
Methotrexate—SLCO3A1—urethra—chronic kidney failure	0.000579	0.00589	CbGeAlD
Methotrexate—SLC22A6—cortex of kidney—chronic kidney failure	0.000577	0.00587	CbGeAlD
Methotrexate—PGD—nephron tubule—chronic kidney failure	0.000572	0.00582	CbGeAlD
Methotrexate—SLCO3A1—kidney—chronic kidney failure	0.00057	0.00579	CbGeAlD
Methotrexate—SLCO3A1—cortex of kidney—chronic kidney failure	0.000555	0.00564	CbGeAlD
Methotrexate—DHFR—renal system—chronic kidney failure	0.000541	0.0055	CbGeAlD
Methotrexate—DHFR—cardiovascular system—chronic kidney failure	0.000535	0.00544	CbGeAlD
Methotrexate—SLC22A11—digestive system—chronic kidney failure	0.000534	0.00543	CbGeAlD
Methotrexate—DHFR—urethra—chronic kidney failure	0.000532	0.0054	CbGeAlD
Methotrexate—SLCO3A1—gonad—chronic kidney failure	0.000529	0.00537	CbGeAlD
Methotrexate—DHFR—kidney—chronic kidney failure	0.000523	0.00532	CbGeAlD
Methotrexate—SLC22A7—digestive system—chronic kidney failure	0.000521	0.0053	CbGeAlD
Methotrexate—PGD—renal system—chronic kidney failure	0.00052	0.00529	CbGeAlD
Methotrexate—TYMS—cortex of kidney—chronic kidney failure	0.000515	0.00523	CbGeAlD
Methotrexate—PGD—cardiovascular system—chronic kidney failure	0.000514	0.00523	CbGeAlD
Methotrexate—PGD—urethra—chronic kidney failure	0.000511	0.0052	CbGeAlD
Methotrexate—DHFR—cortex of kidney—chronic kidney failure	0.00051	0.00518	CbGeAlD
Methotrexate—AOX1—nephron tubule—chronic kidney failure	0.000504	0.00513	CbGeAlD
Methotrexate—PGD—kidney—chronic kidney failure	0.000503	0.00511	CbGeAlD
Methotrexate—MTHFR—digestive system—chronic kidney failure	0.000491	0.00499	CbGeAlD
Methotrexate—TYMS—gonad—chronic kidney failure	0.00049	0.00498	CbGeAlD
Methotrexate—PGD—cortex of kidney—chronic kidney failure	0.00049	0.00498	CbGeAlD
Methotrexate—SLC16A1—renal system—chronic kidney failure	0.000486	0.00494	CbGeAlD
Methotrexate—DHFR—gonad—chronic kidney failure	0.000485	0.00493	CbGeAlD
Methotrexate—SLC16A1—cardiovascular system—chronic kidney failure	0.00048	0.00488	CbGeAlD
Methotrexate—SLCO1B1—renal system—chronic kidney failure	0.000473	0.0048	CbGeAlD
Methotrexate—SLC16A1—kidney—chronic kidney failure	0.00047	0.00477	CbGeAlD
Methotrexate—MTHFR—blood—chronic kidney failure	0.000468	0.00476	CbGeAlD
Methotrexate—PGD—gonad—chronic kidney failure	0.000467	0.00474	CbGeAlD
Methotrexate—SLCO3A1—blood—chronic kidney failure	0.000461	0.00468	CbGeAlD
Methotrexate—AOX1—renal system—chronic kidney failure	0.000458	0.00466	CbGeAlD
Methotrexate—SLCO1B1—kidney—chronic kidney failure	0.000457	0.00464	CbGeAlD
Methotrexate—AOX1—urethra—chronic kidney failure	0.00045	0.00458	CbGeAlD
Methotrexate—TYMS—digestive system—chronic kidney failure	0.000448	0.00456	CbGeAlD
Methotrexate—ABCC3—renal system—chronic kidney failure	0.000448	0.00456	CbGeAlD
Methotrexate—ABCC10—renal system—chronic kidney failure	0.000446	0.00454	CbGeAlD
Methotrexate—DHFR—digestive system—chronic kidney failure	0.000444	0.00451	CbGeAlD
Methotrexate—AOX1—kidney—chronic kidney failure	0.000443	0.0045	CbGeAlD
Methotrexate—ABCC10—urethra—chronic kidney failure	0.000438	0.00445	CbGeAlD
Methotrexate—SLC16A1—gonad—chronic kidney failure	0.000436	0.00443	CbGeAlD
Methotrexate—ABCC3—kidney—chronic kidney failure	0.000433	0.00441	CbGeAlD
Methotrexate—AOX1—cortex of kidney—chronic kidney failure	0.000432	0.00439	CbGeAlD
Methotrexate—ABCC10—kidney—chronic kidney failure	0.000431	0.00438	CbGeAlD
Methotrexate—TYMS—blood—chronic kidney failure	0.000427	0.00434	CbGeAlD
Methotrexate—PGD—digestive system—chronic kidney failure	0.000427	0.00434	CbGeAlD
Methotrexate—DHFR—blood—chronic kidney failure	0.000423	0.0043	CbGeAlD
Methotrexate—ABCC10—cortex of kidney—chronic kidney failure	0.00042	0.00427	CbGeAlD
Methotrexate—AOX1—gonad—chronic kidney failure	0.000411	0.00418	CbGeAlD
Methotrexate—ABCC4—nephron tubule—chronic kidney failure	0.000407	0.00414	CbGeAlD
Methotrexate—PGD—blood—chronic kidney failure	0.000407	0.00413	CbGeAlD
Methotrexate—SLC22A8—nephron tubule—chronic kidney failure	0.000404	0.00411	CbGeAlD
Methotrexate—ABCC10—gonad—chronic kidney failure	0.0004	0.00407	CbGeAlD
Methotrexate—SLC16A1—digestive system—chronic kidney failure	0.000398	0.00405	CbGeAlD
Methotrexate—ABCC2—nephron tubule—chronic kidney failure	0.000394	0.00401	CbGeAlD
Methotrexate—SLCO1B1—digestive system—chronic kidney failure	0.000388	0.00394	CbGeAlD
Methotrexate—SLCO1A2—renal system—chronic kidney failure	0.000385	0.00391	CbGeAlD
Methotrexate—AOX1—digestive system—chronic kidney failure	0.000376	0.00382	CbGeAlD
Methotrexate—SLCO1A2—kidney—chronic kidney failure	0.000372	0.00378	CbGeAlD
Methotrexate—ABCC4—renal system—chronic kidney failure	0.00037	0.00376	CbGeAlD
Methotrexate—SLCO1B1—blood—chronic kidney failure	0.000369	0.00375	CbGeAlD
Methotrexate—ABCC3—digestive system—chronic kidney failure	0.000368	0.00374	CbGeAlD
Methotrexate—SLC22A8—renal system—chronic kidney failure	0.000367	0.00373	CbGeAlD
Methotrexate—ABCC10—digestive system—chronic kidney failure	0.000366	0.00372	CbGeAlD
Methotrexate—ABCC2—renal system—chronic kidney failure	0.000358	0.00364	CbGeAlD
Methotrexate—ABCC4—kidney—chronic kidney failure	0.000358	0.00364	CbGeAlD
Methotrexate—SLC22A8—kidney—chronic kidney failure	0.000355	0.00361	CbGeAlD
Methotrexate—ABCC3—blood—chronic kidney failure	0.00035	0.00356	CbGeAlD
Methotrexate—ABCC10—blood—chronic kidney failure	0.000349	0.00354	CbGeAlD
Methotrexate—ABCC4—cortex of kidney—chronic kidney failure	0.000348	0.00354	CbGeAlD
Methotrexate—ABCC2—kidney—chronic kidney failure	0.000346	0.00352	CbGeAlD
Methotrexate—SLC22A8—cortex of kidney—chronic kidney failure	0.000346	0.00351	CbGeAlD
Methotrexate—ABCC2—cortex of kidney—chronic kidney failure	0.000337	0.00343	CbGeAlD
Methotrexate—SLCO1A2—digestive system—chronic kidney failure	0.000315	0.00321	CbGeAlD
Methotrexate—ABCC1—urethra—chronic kidney failure	0.00031	0.00315	CbGeAlD
Methotrexate—ABCC4—digestive system—chronic kidney failure	0.000304	0.00309	CbGeAlD
Methotrexate—ABCC1—cortex of kidney—chronic kidney failure	0.000297	0.00302	CbGeAlD
Methotrexate—ABCC2—digestive system—chronic kidney failure	0.000294	0.00299	CbGeAlD
Methotrexate—ABCC4—blood—chronic kidney failure	0.000289	0.00294	CbGeAlD
Methotrexate—ABCG2—nephron tubule—chronic kidney failure	0.000287	0.00292	CbGeAlD
Methotrexate—SLC22A8—blood—chronic kidney failure	0.000287	0.00292	CbGeAlD
Methotrexate—ABCC2—blood—chronic kidney failure	0.00028	0.00285	CbGeAlD
Methotrexate—ABCB1—blood plasma—chronic kidney failure	0.000275	0.00279	CbGeAlD
Methotrexate—ABCG2—urethra—chronic kidney failure	0.000257	0.00261	CbGeAlD
Methotrexate—ABCC1—blood—chronic kidney failure	0.000247	0.00251	CbGeAlD
Methotrexate—ABCG2—blood—chronic kidney failure	0.000204	0.00207	CbGeAlD
Methotrexate—ABCB1—nephron tubule—chronic kidney failure	0.000142	0.00144	CbGeAlD
Methotrexate—ABCB1—renal system—chronic kidney failure	0.000129	0.00131	CbGeAlD
Methotrexate—ABCB1—cardiovascular system—chronic kidney failure	0.000127	0.00129	CbGeAlD
Methotrexate—ABCB1—urethra—chronic kidney failure	0.000127	0.00129	CbGeAlD
Methotrexate—ABCB1—kidney—chronic kidney failure	0.000125	0.00127	CbGeAlD
Methotrexate—ABCB1—cortex of kidney—chronic kidney failure	0.000121	0.00123	CbGeAlD
Methotrexate—ABCB1—gonad—chronic kidney failure	0.000116	0.00117	CbGeAlD
Methotrexate—ABCB1—digestive system—chronic kidney failure	0.000106	0.00107	CbGeAlD
Methotrexate—ABCB1—blood—chronic kidney failure	0.000101	0.00102	CbGeAlD
Methotrexate—ABCB1—Metabolism—MLXIPL—chronic kidney failure	9.26e-06	5.31e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SCARB1—chronic kidney failure	9.21e-06	5.27e-05	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—KRAS—chronic kidney failure	9.2e-06	5.27e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS1—chronic kidney failure	9.11e-06	5.22e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—TGFB1—chronic kidney failure	9.09e-06	5.21e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HBEGF—chronic kidney failure	9.07e-06	5.2e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS3—chronic kidney failure	9.07e-06	5.19e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CYP1A1—chronic kidney failure	9.06e-06	5.19e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ABCB1—chronic kidney failure	9.03e-06	5.17e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CPT1A—chronic kidney failure	9e-06	5.15e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCG1—chronic kidney failure	8.99e-06	5.15e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	8.96e-06	5.14e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SREBF1—chronic kidney failure	8.94e-06	5.12e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—chronic kidney failure	8.93e-06	5.12e-05	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ALB—chronic kidney failure	8.9e-06	5.1e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS3—chronic kidney failure	8.86e-06	5.07e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—MTHFR—chronic kidney failure	8.81e-06	5.05e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PIP5K1B—chronic kidney failure	8.79e-06	5.04e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—LIPC—chronic kidney failure	8.77e-06	5.02e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP2C19—chronic kidney failure	8.77e-06	5.02e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CYP3A4—chronic kidney failure	8.76e-06	5.02e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SCARB1—chronic kidney failure	8.75e-06	5.01e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	8.72e-06	4.99e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—POMC—chronic kidney failure	8.71e-06	4.99e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—HMGCR—chronic kidney failure	8.69e-06	4.98e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS1—chronic kidney failure	8.66e-06	4.96e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PPARA—chronic kidney failure	8.64e-06	4.95e-05	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ALB—chronic kidney failure	8.62e-06	4.94e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ARG2—chronic kidney failure	8.62e-06	4.94e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ABCA1—chronic kidney failure	8.61e-06	4.93e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—LPL—chronic kidney failure	8.6e-06	4.93e-05	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ALB—chronic kidney failure	8.52e-06	4.88e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	8.52e-06	4.88e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—FASN—chronic kidney failure	8.51e-06	4.87e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—POMC—chronic kidney failure	8.5e-06	4.87e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SREBF1—chronic kidney failure	8.49e-06	4.87e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SLC22A2—chronic kidney failure	8.47e-06	4.85e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LCAT—chronic kidney failure	8.45e-06	4.84e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—MTHFR—chronic kidney failure	8.44e-06	4.84e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—SERPINE1—chronic kidney failure	8.44e-06	4.83e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—KRAS—chronic kidney failure	8.42e-06	4.82e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CAT—chronic kidney failure	8.37e-06	4.8e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CYP1A1—chronic kidney failure	8.31e-06	4.76e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PTGS2—chronic kidney failure	8.29e-06	4.75e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PPARA—chronic kidney failure	8.28e-06	4.74e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—HMGCR—chronic kidney failure	8.26e-06	4.73e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ABCB1—chronic kidney failure	8.14e-06	4.67e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—VEGFA—chronic kidney failure	8.14e-06	4.66e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SCARB1—chronic kidney failure	8.1e-06	4.64e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic kidney failure	8.1e-06	4.64e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—PTGS2—chronic kidney failure	8.1e-06	4.64e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—FASN—chronic kidney failure	8.09e-06	4.63e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS3—chronic kidney failure	8.06e-06	4.62e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS1—chronic kidney failure	8.02e-06	4.59e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ALB—chronic kidney failure	7.94e-06	4.55e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CYP3A4—chronic kidney failure	7.88e-06	4.52e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ABCG1—chronic kidney failure	7.87e-06	4.51e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SREBF1—chronic kidney failure	7.86e-06	4.51e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	7.84e-06	4.49e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—LPL—chronic kidney failure	7.76e-06	4.45e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—DDC—chronic kidney failure	7.76e-06	4.44e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—chronic kidney failure	7.75e-06	4.44e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ALB—chronic kidney failure	7.75e-06	4.44e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ABCA1—chronic kidney failure	7.75e-06	4.44e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—MTHFR—chronic kidney failure	7.74e-06	4.44e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—POMC—chronic kidney failure	7.74e-06	4.43e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PIP5K1B—chronic kidney failure	7.71e-06	4.41e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—HMGCR—chronic kidney failure	7.65e-06	4.38e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—AVP—chronic kidney failure	7.64e-06	4.38e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PPARA—chronic kidney failure	7.6e-06	4.35e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—NOS3—chronic kidney failure	7.59e-06	4.35e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ARG2—chronic kidney failure	7.55e-06	4.32e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PRKD1—chronic kidney failure	7.53e-06	4.31e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP2B6—chronic kidney failure	7.53e-06	4.31e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PRKAG2—chronic kidney failure	7.53e-06	4.31e-05	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ALB—chronic kidney failure	7.5e-06	4.3e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CYP1A1—chronic kidney failure	7.5e-06	4.29e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CYP3A4—chronic kidney failure	7.49e-06	4.29e-05	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—chronic kidney failure	7.49e-06	4.29e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—FASN—chronic kidney failure	7.49e-06	4.29e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TGFB1—chronic kidney failure	7.47e-06	4.28e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	7.45e-06	4.27e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NOS3—chronic kidney failure	7.42e-06	4.25e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	7.41e-06	4.25e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LCAT—chronic kidney failure	7.4e-06	4.24e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	7.4e-06	4.24e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—PTGS2—chronic kidney failure	7.37e-06	4.22e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ABCA1—chronic kidney failure	7.36e-06	4.22e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CAT—chronic kidney failure	7.29e-06	4.18e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—LPL—chronic kidney failure	7.26e-06	4.16e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	7.16e-06	4.1e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic kidney failure	7.15e-06	4.09e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ABCB1—chronic kidney failure	7.09e-06	4.06e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ALB—chronic kidney failure	7.05e-06	4.04e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SREBF2—chronic kidney failure	7.05e-06	4.04e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—POMC—chronic kidney failure	7.05e-06	4.04e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic kidney failure	7.04e-06	4.03e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—MTHFR—chronic kidney failure	6.99e-06	4e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTGS2—chronic kidney failure	6.94e-06	3.98e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP3A4—chronic kidney failure	6.94e-06	3.97e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PLAU—chronic kidney failure	6.92e-06	3.97e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—KRAS—chronic kidney failure	6.92e-06	3.97e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PPARA—chronic kidney failure	6.86e-06	3.93e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—chronic kidney failure	6.85e-06	3.92e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ABCA1—chronic kidney failure	6.82e-06	3.91e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GCKR—chronic kidney failure	6.81e-06	3.9e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCC3—chronic kidney failure	6.81e-06	3.9e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—DDC—chronic kidney failure	6.8e-06	3.89e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTGS2—chronic kidney failure	6.78e-06	3.89e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—LPL—chronic kidney failure	6.76e-06	3.87e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—POMC—chronic kidney failure	6.75e-06	3.87e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NOS3—chronic kidney failure	6.75e-06	3.87e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—AVP—chronic kidney failure	6.69e-06	3.83e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CCR5—chronic kidney failure	6.69e-06	3.83e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LPIN1—chronic kidney failure	6.67e-06	3.82e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PRKAG2—chronic kidney failure	6.6e-06	3.78e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP2B6—chronic kidney failure	6.6e-06	3.78e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PRKD1—chronic kidney failure	6.6e-06	3.78e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic kidney failure	6.56e-06	3.76e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CAT—chronic kidney failure	6.56e-06	3.76e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	6.55e-06	3.75e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MTHFR—chronic kidney failure	6.54e-06	3.75e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP2C18—chronic kidney failure	6.53e-06	3.74e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LRP2—chronic kidney failure	6.53e-06	3.74e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CYP1A1—chronic kidney failure	6.53e-06	3.74e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic kidney failure	6.46e-06	3.7e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—F2—chronic kidney failure	6.44e-06	3.69e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ALB—chronic kidney failure	6.42e-06	3.68e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ABCB1—chronic kidney failure	6.38e-06	3.66e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CAT—chronic kidney failure	6.23e-06	3.57e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—PPARA—chronic kidney failure	6.23e-06	3.57e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—POMC—chronic kidney failure	6.19e-06	3.55e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SREBF2—chronic kidney failure	6.18e-06	3.54e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTGS2—chronic kidney failure	6.17e-06	3.54e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ALB—chronic kidney failure	6.16e-06	3.53e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NOS3—chronic kidney failure	6.15e-06	3.52e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—MTHFR—chronic kidney failure	6.08e-06	3.49e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—LPL—chronic kidney failure	6.08e-06	3.48e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ABCB1—chronic kidney failure	6.06e-06	3.47e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic kidney failure	6.03e-06	3.46e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TGFB1—chronic kidney failure	6e-06	3.43e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—chronic kidney failure	5.98e-06	3.43e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARA—chronic kidney failure	5.97e-06	3.42e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ABCC3—chronic kidney failure	5.97e-06	3.42e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GCKR—chronic kidney failure	5.97e-06	3.42e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NOS3—chronic kidney failure	5.89e-06	3.37e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CYP1A1—chronic kidney failure	5.87e-06	3.36e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—TGFB1—chronic kidney failure	5.86e-06	3.35e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LPIN1—chronic kidney failure	5.84e-06	3.35e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—LPL—chronic kidney failure	5.78e-06	3.31e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CAT—chronic kidney failure	5.77e-06	3.31e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP2C18—chronic kidney failure	5.72e-06	3.28e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LRP2—chronic kidney failure	5.72e-06	3.28e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ALB—chronic kidney failure	5.65e-06	3.23e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IGF1—chronic kidney failure	5.64e-06	3.23e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGS2—chronic kidney failure	5.62e-06	3.22e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ABCB1—chronic kidney failure	5.62e-06	3.22e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—POMC—chronic kidney failure	5.59e-06	3.2e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CYP1A1—chronic kidney failure	5.58e-06	3.2e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—KRAS—chronic kidney failure	5.55e-06	3.18e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CPT1A—chronic kidney failure	5.55e-06	3.18e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—MTHFR—chronic kidney failure	5.48e-06	3.14e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—PPARA—chronic kidney failure	5.46e-06	3.13e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IRS1—chronic kidney failure	5.43e-06	3.11e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—KRAS—chronic kidney failure	5.42e-06	3.11e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LIPC—chronic kidney failure	5.41e-06	3.1e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP2C19—chronic kidney failure	5.41e-06	3.1e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NOS3—chronic kidney failure	5.4e-06	3.09e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS2—chronic kidney failure	5.39e-06	3.08e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARA—chronic kidney failure	5.37e-06	3.08e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SERPINE1—chronic kidney failure	5.36e-06	3.07e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—LPL—chronic kidney failure	5.35e-06	3.07e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	5.34e-06	3.06e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFB1—chronic kidney failure	5.33e-06	3.05e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MTHFR—chronic kidney failure	5.2e-06	2.98e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP1A1—chronic kidney failure	5.17e-06	2.96e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS3—chronic kidney failure	5.11e-06	2.93e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARA—chronic kidney failure	5.1e-06	2.92e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALB—chronic kidney failure	5.09e-06	2.92e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SCARB1—chronic kidney failure	5e-06	2.86e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS1—chronic kidney failure	4.95e-06	2.83e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS2—chronic kidney failure	4.94e-06	2.83e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—KRAS—chronic kidney failure	4.93e-06	2.83e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NOS3—chronic kidney failure	4.87e-06	2.79e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—POMC—chronic kidney failure	4.87e-06	2.79e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CPT1A—chronic kidney failure	4.86e-06	2.79e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SREBF1—chronic kidney failure	4.85e-06	2.78e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MTHFR—chronic kidney failure	4.82e-06	2.76e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SERPINE1—chronic kidney failure	4.78e-06	2.74e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LIPC—chronic kidney failure	4.74e-06	2.72e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP2C19—chronic kidney failure	4.74e-06	2.72e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARA—chronic kidney failure	4.73e-06	2.71e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HMGCR—chronic kidney failure	4.72e-06	2.7e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—FASN—chronic kidney failure	4.62e-06	2.65e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS3—chronic kidney failure	4.56e-06	2.61e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—chronic kidney failure	4.52e-06	2.59e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS2—chronic kidney failure	4.46e-06	2.55e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALB—chronic kidney failure	4.44e-06	2.54e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—chronic kidney failure	4.41e-06	2.53e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SCARB1—chronic kidney failure	4.38e-06	2.51e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—POMC—chronic kidney failure	4.38e-06	2.51e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS1—chronic kidney failure	4.34e-06	2.48e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP3A4—chronic kidney failure	4.28e-06	2.45e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	4.26e-06	2.44e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SREBF1—chronic kidney failure	4.25e-06	2.44e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NOS3—chronic kidney failure	4.24e-06	2.43e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCA1—chronic kidney failure	4.21e-06	2.41e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTGS2—chronic kidney failure	4.17e-06	2.39e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—POMC—chronic kidney failure	4.16e-06	2.38e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HMGCR—chronic kidney failure	4.14e-06	2.37e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	4.05e-06	2.32e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—FASN—chronic kidney failure	4.05e-06	2.32e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—chronic kidney failure	4.01e-06	2.3e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALB—chronic kidney failure	3.99e-06	2.29e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS2—chronic kidney failure	3.88e-06	2.22e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—POMC—chronic kidney failure	3.85e-06	2.21e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NOS3—chronic kidney failure	3.82e-06	2.19e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALB—chronic kidney failure	3.79e-06	2.17e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP3A4—chronic kidney failure	3.75e-06	2.15e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ABCA1—chronic kidney failure	3.69e-06	2.11e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—VEGFA—chronic kidney failure	3.68e-06	2.11e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NOS3—chronic kidney failure	3.63e-06	2.08e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CAT—chronic kidney failure	3.56e-06	2.04e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALB—chronic kidney failure	3.51e-06	2.01e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS2—chronic kidney failure	3.49e-06	2e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCB1—chronic kidney failure	3.46e-06	1.98e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB1—chronic kidney failure	3.38e-06	1.94e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NOS3—chronic kidney failure	3.36e-06	1.92e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS2—chronic kidney failure	3.32e-06	1.9e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LPL—chronic kidney failure	3.3e-06	1.89e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP1A1—chronic kidney failure	3.19e-06	1.83e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—KRAS—chronic kidney failure	3.13e-06	1.79e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CAT—chronic kidney failure	3.12e-06	1.79e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS2—chronic kidney failure	3.07e-06	1.76e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFB1—chronic kidney failure	3.02e-06	1.73e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MTHFR—chronic kidney failure	2.97e-06	1.7e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARA—chronic kidney failure	2.92e-06	1.67e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LPL—chronic kidney failure	2.89e-06	1.66e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP1A1—chronic kidney failure	2.79e-06	1.6e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—KRAS—chronic kidney failure	2.79e-06	1.6e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MTHFR—chronic kidney failure	2.6e-06	1.49e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARA—chronic kidney failure	2.56e-06	1.46e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—POMC—chronic kidney failure	2.38e-06	1.36e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—chronic kidney failure	2.27e-06	1.3e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—POMC—chronic kidney failure	2.08e-06	1.19e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NOS3—chronic kidney failure	2.07e-06	1.19e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALB—chronic kidney failure	1.9e-06	1.09e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS2—chronic kidney failure	1.9e-06	1.09e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NOS3—chronic kidney failure	1.82e-06	1.04e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS2—chronic kidney failure	1.66e-06	9.52e-06	CbGpPWpGaD
